MetaThin, a nationwide weight loss program, has announced the signing of 180 Medspa and Behnosh Spa and Wellness, its first two retail outlets to exclusively offer MetaThinâ€™s line of weight loss supplements.
Online PR News – 29-November-2012 – WINTER PARK, FL – "Weâ€™re proud of this significant accomplishment," said MetaThin founder Lisa Lind. "Our whole team is thrilled to see products like our MetaThin Weight Loss Solution 5â€˘8â€˘10 make their way out onto shelves and into customerâ€™s hands through such prestigious and successful day spas."
"Weâ€™re very proud to offer such great weight loss products to our clients," noted 180 Medspaâ€™s owner, Sandy Hutnick. "We researched many products to find out what actually works. With MetaThin we not only have great diet plans, weâ€™ve got the corporate support and distribution to back it up. Theyâ€™re just a great company," she added. A representative at Behnosh Spa and Wellness was also excited about the relationship. "We always align ourselves with the best health and wellness products in the market, we know that our customers are going to love the MetaThin system."
The retail rollout is part of MetaThinâ€™s national expansion plan over the next three years. Retail outlets are carefully selected by a number of criteria that go well beyond location. "We look right down to what kind of management team is in place," explained Lind. â€śMetaThinâ€™s success is based upon a hands-on consultative approach. Itâ€™s essential to have people that understand how the programs works if theyâ€™re going to sell it because there are too many frauds out there. And weâ€™re not about that as a company.â€ť
MetaThin is a complete weight loss program that consists of weight loss supplements along with a coaching and support program, all backed by a money back guarantee. All Metathin products are 100% hormone free and clearly labeled. The amino acids found in MetaThinâ€™s weight loss solution are certified pharmaceutical grade and manufactured according to GMP (Good Manufacturing Practices) in a FDA-monitored facility in the U.S.A.